The problem of SARS-CoV-2 virus resistance to direct-acting antivirals by E. L. Gasich, E. N. Krotkova, A. D. Kasko, K. Yu. Bulda, A. G. Krasko, E. A. Dorofeeva, I. A. Karpov

Get full text

Characteristics of Hepatitis C Epidemic Process in the Republic of Belarus by V. S. Vysotskaya, N. D. Kolomiets, E. L. Gasich, O. N. Hanenko, O. V. Tonko, I. N. Glinskaya, O. N. Romanova, A. N. Kabankova

Get full text

RESULTS OF THE USE OF SOFOSBUVIR IN COMBINATION WITH LEDIPASVIR OR DACLATASVIR FOR CHRONIC HEPATITIS C TREATMENT IN THE REPUBLIC OF BELARUS by S. V. Zhavoronok, V. R. Gutmane, T. M. Baryash, O. V. Soldatenko, T. V. Znovets, V. M. Mitsura, E. V. Voropaev, E. L. Gasich, E. N. Yagovdik-Telezhnaja, L. V. Sivachenko, L. A. Anisko, L. S. Zhmurovskaja, S. V. Krapivina, N. N. Yurovskij, I. V. Yurkevich, I. A. Karpov

Get full text

Evaluation of Immunogenicity of Inactivated Whole-Virion Booster Vaccine against SARS-CoV-2 in a phase I, II Clinical Trial by I. O. Stoma, E. V. Voropaev, E. I. Mikhailova, K. S. Korsak, O. V. Osipkina, A. V. Molchanova, A. A. Kovalev, D. M. Los, A. A. Ziatskov, A. S. Shaforost, M. N. Yatsuk, A. Yu. Braga, N. V. Trofimova, A. M. Dronina, E. L. Gasich, V. A. Gorbunov, A. Ev. Hancharou

Get full text